Literature DB >> 30302227

Primary diffuse large B-cell lymphoma of the CNS: a rare case of spontaneous remission.

Fotini Debonera1, Sunita Nasta1, Maria Martinez-Lage1, Stephen J Schuster1, Donald E Tsai1.   

Abstract

There is no consensus on the optimal therapy for primary CNS lymphoma. Conventional treatment modalities include chemotherapy and radiation therapy, which carry significant risks of morbidity and mortality. In systemic lymphomas, there are situations where non-Hodgkin lymphomas have resolved spontaneously. We now report the case of a nonimmunocompromised patient with primary CNS lymphoma who underwent a spontaneous remission with a durable response. This case suggests that not all patients with primary CNS lymphomas require aggressive treatment with chemotherapy and radiation therapy.

Entities:  

Keywords:  Epstein-Barr virus; elderly patients; immune compromise; incidental tumors; non-Hodgkin lymphoma; primary CNS lymphoma; spontaneous remission; steroids; vanishing tumors

Year:  2017        PMID: 30302227      PMCID: PMC6171994          DOI: 10.2217/ijh-2017-0009

Source DB:  PubMed          Journal:  Int J Hematol Oncol        ISSN: 2045-1393


  17 in total

1.  Primary central nervous system lymphoma: time to ask the question.

Authors:  Howard A Fine
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

Review 2.  Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature.

Authors:  S C Remick; C Diamond; J A Migliozzi; O Solis; H Wagner; R F Haase; J C Ruckdeschel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

Review 3.  Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature.

Authors:  Rokuo Abe; Kazuei Ogawa; Yukio Maruyama; Naoya Nakamura; Masafumi Abe
Journal:  J Clin Exp Hematop       Date:  2007-04

4.  Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.

Authors:  D F Nelson; K L Martz; H Bonner; J S Nelson; J Newall; H D Kerman; J W Thomson; K J Murray
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.

Authors:  Antonio Omuro; Denise D Correa; Lisa M DeAngelis; Craig H Moskowitz; Matthew J Matasar; Thomas J Kaley; Igor T Gavrilovic; Craig Nolan; Elena Pentsova; Christian C Grommes; Katherine S Panageas; Raymond E Baser; Geraldine Faivre; Lauren E Abrey; Craig S Sauter
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

6.  Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?

Authors:  Yoshiko Okita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Shintaro Fukushima; Akiko Maeshima; Takamasa Kayama; Soichiro Shibui
Journal:  Clin Neurol Neurosurg       Date:  2012-03-22       Impact factor: 1.876

Review 7.  Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder.

Authors:  Tracy T Batchelor; Lim Soon Thye; Thomas M Habermann
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 8.  Age-dependent dysregulation of innate immunity.

Authors:  Albert C Shaw; Daniel R Goldstein; Ruth R Montgomery
Journal:  Nat Rev Immunol       Date:  2013-10-25       Impact factor: 53.106

9.  Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases.

Authors:  J G Krikorian; C S Portlock; P Cooney; S A Rosenberg
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

10.  Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Authors:  James L Rubenstein; Eric D Hsi; Jeffrey L Johnson; Sin-Ho Jung; Megan O Nakashima; Barbara Grant; Bruce D Cheson; Lawrence D Kaplan
Journal:  J Clin Oncol       Date:  2013-04-08       Impact factor: 44.544

View more
  1 in total

1.  Vanishing Brain Lesions in a Patient with Vision Loss and Ataxia: A Case of CNS Lymphoma with Corticosteroid Related Regression.

Authors:  Arunmozhimaran Elavarasi; Shilpa Rao; Subasree Ramakrishnan; Dhananjay Bhatt
Journal:  Ann Indian Acad Neurol       Date:  2022-01-13       Impact factor: 1.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.